Novandi Chemistry AB
Anders Bøgevig is a seasoned professional in the field of chemistry with a strong background in organic chemistry, synthesis, and cheminformatics. With extensive experience in various roles ranging from CEO to founder to senior scientist, Anders has demonstrated expertise in process development, synthetic chemistry, and research leadership. Anders holds a Ph.D in Chemistry from Aarhus University and has worked with reputable companies such as AstraZeneca and RISE Research Institutes of Sweden. Currently, Anders is actively involved in Novandi Chemistry AB as a Senior Scientist and in Ursapiens Scientific as a Founder.
This person is not in any teams
Novandi Chemistry AB
Novandi Chemistry's mission is to deliver isotope labeling of substances, chemistry support for nuclear medicine applications, consulting services and R&D in isotope and radiopharmaceutical chemistry. The company offers a comprehensive carbon-14, tritium and stable labeling service and acts as a hub for non-regulatory and regulatory compliant studies with radiolabeled compounds and drug candidates. The company offers a long-term responsibility for radioactive labeled substances through storage, continuous quality control and repurification. Thus, the company can guarantee high quality compounds and simplify the logistics of studies with radiolabeled compounds. The company also offers a general chemistry support for nuclear medicine applications such as positron emission tomography, and consulting service in isotope chemistry, radiation safety (beta radiation), radioligand development and radiopharmaceutical chemistry.